Americans aren't giving Biden much credit for his popular Medicare drug price negotiations, AP-NORC poll says

Three-quarters of Americans , or 76 percent , favor allowing Medicare to negotiate prices for certain prescription drugs.

That includes strong majorities of Democrats ( 86 percent ) and Republicans ( 66 percent ) Americans are split on how the Democratic president is handling the issue of prescription drug prices.

Even among the Americans who support the new Medicare policy, approval of Biden ’s handling of the issue remains relatively tepid.

It will take three years for the lower prices for the 10 drugs to go into effect, and the industry’s lobbying group, Pharmaceutical Research and Manufacturers of America , has already sued the administration to halt the plan.

But Centers for Medicare and Medicaid Services will add 15 more drugs to its negotiation list for 2027 and another 15 for 2028 .